Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia [Phase 2]
Phase 2 trial results for CVL-231 (Emraclidine) in adults with schizophrenia have been completed with results posted. The study evaluated sa…
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia [NA]
Clinical trial investigating low-dose levetiracetam effects on symptoms, cognition, and hippocampal activity in schizophrenia; completed wit…
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: Metformin Treatment on Cognitive Impairment of Schizophrenia [Phase 3]
Phase 3 clinical trial investigating metformin for cognitive impairment in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia [NA]
Completed clinical trial studying behavioral impact and neural correlates of network-based brain stimulation in schizophrenia and nicotine u…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Personalized and Scalable Cognitive Remediation Approaches [NA]
Completed clinical trial evaluating personalized and scalable cognitive remediation for schizophrenia-spectrum conditions; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of TV-44749 in Chinese patients with schizophrenia has completed with re…
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia [NA]
A terminated clinical trial evaluating the use of transcranial magnetic stimulation (TMS) to understand negative symptoms in schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia [Phase 3]
Phase 3 trial evaluating safety and effectiveness of slowly increasing dose and food effect of KarXT in participants with schizophrenia; stu…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents [Phase 1]
Phase 1 pharmacokinetics and tolerability study of aripiprazole in children and adolescents with schizophrenia or mania completed; results p…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia [Phase 3]
A Phase 3 clinical trial assessing the efficacy and safety of an investigational drug for acutely psychotic schizophrenia has completed with…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Metformin Treatment on Cognitive Impairment of Schizophrenia [Phase 3]
Phase 3 clinical trial investigating metformin for cognitive impairment in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis [Phase 4]
Phase 4 clinical trial assessing GABA function in psychosis across schizophrenia and bipolar disorder; results completed and posted in 2026.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia [Phase 3]
Extension study results for a second course of a digital therapeutic targeting experiential negative symptoms in schizophrenia, completed P…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Biomarkers to Enhance Early Schizophrenia Treatment [Phase 4]
Phase 4 clinical trial investigating biomarkers to improve early treatment of schizophrenia.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Schizophrenia [Phase 2]
Phase 2 clinical trial update assessing the efficacy and safety of HS-10380 in hospitalized adults with acute schizophrenia.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Genetic Study of Schizophrenia
A completed genetic study update investigating schizophrenia. The conditions include schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Inpatient Evaluation of Adults With Schizophrenia
This is a completed clinical trial update from the National Institute of Mental Health evaluating inpatient care for adults with schizophren…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Studies of Frontal Lobe Brain Functioning in Schizophrenia
This clinical trial update from the National Institute of Mental Health indicates completion of studies examining frontal lobe brain functio…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode [Phase 1]
Phase 1 clinical trial update shows the SEP-380135 study in adults with schizophrenia or major depressive episode has completed. The trial s…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients [NA]
A completed clinical trial evaluating Ashwagandha as an adjunct therapy to assess effects on BDNF levels and cognitive function in schizophr…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Luteolin for the Treatment of People With Schizophrenia [NA]
Sponsored by the University of Maryland, Baltimore, a clinical trial evaluating luteolin for schizophrenia and schizoaffective disorder has …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia [NA]
An investigation using deep rTMS to modulate insula synaptic density and smoking behavior in individuals with schizophrenia has been termina…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine [Phase 1, Phase 2]
The update covers a subcutaneous long-acting cariprazine depot studied in Phase 1/2 for pharmacokinetics, safety, tolerability, and efficacy…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients [NA]
A completed clinical trial evaluated whether cognitive behavioral therapy reduces auditory hallucinations and neutrophil-to-lymphocyte ratio…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders. [NA]
A completed clinical trial evaluated whether adding Pediococcus acidilactici to antipsychotic therapy improves metabolic syndrome disturbanc…